Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Ixiaro and streptozocin

Results for the following 2 drugs:
Ixiaro (japanese enceph vacc sa14-14-2, inactivated)
streptozocin

Interactions between your drugs

Moderate

streptozocin Japanese enceph vacc SA14-14-2, inactivated

Applies to: streptozocin and Ixiaro (japanese enceph vacc sa14-14-2, inactivated)

If you are currently being treated or have recently been treated with streptozocin, you should let your doctor know before receiving Japanese enceph vacc SA14-14-2, inactivated. Depending on the dose and length of time you have been on streptozocin, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of streptozocin therapy. If you have recently been vaccinated with Japanese enceph vacc SA14-14-2, inactivated, your doctor may choose to postpone treatment with streptozocin for a couple of weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

No results found in our database - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide